Shandong Drug Administration Announces the Inspection Results of Drug Market (No.6, 2022)

Shandong Drug Administration Announces the Inspection Results of Drug Market (No.6, 2022)

image.png

China Quality News Network News On September 6, 2022, the website of Shandong Drug Administration issued a notice on the inspection results of the drug market (No.6, 2022).

The notice shows that according toChinathe peoplerepublicDrug Administration Law and other laws, regulations and rules. Recently, Shandong Food and Drug Administration organized GSP compliance inspection, key inspection and causal inspection for 43 drug wholesale enterprises and drug retail chain headquarters; 25 drug retail enterprises and users were investigated.extendCheck. The inspection results are as follows:

I. Pharmaceutical wholesale enterprises

40 pharmaceutical wholesale enterprises were inspected, and 38 of them basically met the requirements of drug GSP, and the local inspection sub-bureau supervised the rectification; 1 does not meet the requirements of drug GSP, and the local inspection branch will investigate and deal with it and investigate it according to law; One enterprise has taken the initiative to apply for suspension of operation before the inspection.

Second, the pharmaceutical retail chain headquarters

The headquarters of three pharmaceutical retail chain enterprises were inspected, all of which basically met the requirements of drug GSP, and the local inspection sub-bureau supervised the rectification.

Third, retail pharmacies

Extended inspections were conducted on 7 retail pharmacies, of which 1 extended inspection project found no problems and 6 had defects, and the local market supervision department supervised the rectification.

Fourth, drug users

Extended inspection was conducted on 18 drug users, among which 5 extended inspection items found no problems and 13 had defects, and the local market supervision department supervised the rectification.

Attachment:

Check the list of enterprises (units)

I. Enterprises (units) that basically meet the requirements

Key inspections (9): Shandong Kanghui Pharmaceutical Co., Ltd., Luyao Group Zibo Pharmaceutical Co., Ltd., Shandong Rui Kang Hai Jian Pharmaceutical Co., Ltd., Ruikang Pharmaceutical Group Co., Ltd., Shangyao Holdings (Yantai) Co., Ltd., Shandong Deyuchang Pharmaceutical Co., Ltd., Shandong Kangnuo Shengshi Pharmaceutical Co., Ltd., Shandong Liaocheng Limin Pharmaceutical Group Co., Ltd., Shandong Qidian Medical Co., Ltd.

GSP compliance inspection (32 companies): Shandong Fukang Pharmaceutical Co., Ltd., Shandong Sanzhu Pharmaceutical Management Co., Ltd., Zibo Hengan Pharmaceutical Co., Ltd., Shandong Xinhua Pharmaceutical Trading Co., Ltd. Luzhong Branch, Zibo Shanhe Pharmaceutical Co., Ltd., Zibo Tianlong Pharmaceutical Co., Ltd., Zibo World Expo Jindu Medical Device Co., Ltd. Pharmaceutical Sales Branch, Shandong Zibo Haiya Pharmaceutical Co., Ltd., Shandong Kangcheng Pharmaceutical Co., Ltd., Yinhe Pharmaceutical (Shandong) Co., Ltd., Yantai Minkang Medicine Co., Ltd., Weihai Tianfu Medicine Co., Ltd., Shandong Ruihong Medicine Co., Ltd., Shandong Jin Kang Medicine Co., Ltd., Shandong Hongci Tongkang Medicine Co., Ltd., Shandong Zhongzhi Medicine Co., Ltd., Beijing Tongren Tang Shandong Pharmaceutical Chain Co., Ltd., Zhaoyuan Medicine Co., Ltd., Yantai Kang Hua Pharmacy Co., Ltd., Yantai Minfeng Medicine Co., Ltd., China Resources Yantai Medicine Co., Ltd., Yantai Haizheng Pharmaceutical Co., Ltd. Weifang Yu Xiang Pharmaceutical Co., Ltd., Shandong Jianqiao Pharmaceutical Co., Ltd., Liaocheng Ruikang Renhe Pharmaceutical Co., Ltd., Shangdong Pharmaceutical Holdings Co., Ltd. Liaocheng Branch, Shandong Ruihui Pharmacy Chain Co., Ltd., Shandong Luoxin Pharmaceutical Group Runxin Pharmaceutical Co., Ltd., Shandong Tingxing Pharmaceutical Co., Ltd., Shandong Donge County Pharmaceutical Company, Shandong Yirentang Pharmaceutical Co., Ltd., Jinan Lijian Pharmacy Co., Ltd.

Extended inspection of retail pharmacies (6 stores): Laizhou No.1 Store of Beijing Tongrentang Shandong Pharmaceutical Chain Co., Ltd., Laizhou No.2 Store of Beijing Tongrentang Shandong Pharmaceutical Chain Co., Ltd., Yantai Uni-President Pharmacy Co., Ltd. No.1 Branch, Yantai Kang Hua Pharmacy Co., Ltd. Longkou Yitai Store, Jinan Lijian Pharmacy Co., Ltd. Emerald Bund Store and Jinan Lijian Pharmacy Co., Ltd. Lishan North Road Store.

Extended inspection units (13): Zibo Gaoxin Huageng Hospital, Zhangdian District Stadium Street Rendong Community Health Service Station, Zouping High-tech Street Community Health Service Center, Zouping Changshan Central Health Center, Yantai Zhifu District Tongshen Street Community Health Service Center, Yantai Zhifu District Qishan Street Community Health Service Center, Yantai Qishan Hospital, Yantai Laizhou Rongjun Hospital, Laizhou People’s Hospital, Liaocheng City.

Second, the list of enterprises that do not meet the requirements of GSP

Shandong Putian drug co., ltd. (due to inspection)

Third, no problems were found in the extended inspection project.

Retail drugstore (1): Yantai Xinfutai Drugstore Co., Ltd.

Users (5 companies): Weifang Fangzi District People’s Hospital, Weifang Fangzi Fenghe Hospital, Yantai Zhifu District Xingfu Hospital, Yantai Yuhuangding Hospital, Shandong Wendeng Osteopathic Yantai Hospital Co., Ltd.

Fourth, others 

Active application for business suspension (1 company): Yantai Qilin Pharmaceutical Co., Ltd.

关于作者

admin administrator